Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

iodine-131-tositumomab

Known as: I 131 Monoclonal Antibody Anti-B1, tositumomab iodine i 131, Iodine I 131 Monoclonal Antibody Anti-B1 
A monoclonal antibody (tositumomab) that has been chemically changed by adding radioactive iodine, and that is used in the treatment of certain types… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
PURPOSE This clinical trial evaluated standard-dose radioimmunotherapy with a chemotherapy-based transplantation regimen followed… Expand
  • figure 1
  • table 1
  • figure 2
  • table 3
  • figure 3
Is this relevant?
Highly Cited
2013
Highly Cited
2013
PURPOSE Advanced follicular lymphomas (FL) are considered incurable with conventional chemotherapy and there is no consensus on… Expand
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Therapeutic monoclonal antibodies (mAbs) are currently being approved for marketing in Europe and the United States, as well as… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Advanced-stage follicular B-cell lymphoma is considered incurable. Anti-CD20 radioimmunotherapy is effective in… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE This study is an integrated efficacy analysis of the five clinical trials of tositumomab and iodine-131 tositumomab in… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE To determine overall response (OR) and complete response (CR) rates, response duration, progression-free (PFS) and… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
OBJECTIVE The objective of this study was to evaluate the technique, efficacy, and side effects of percutaneous ethanol injection… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Complement-dependent cytotoxicity is thought to be an important mechanism of action of the anti-CD20 monoclonal antibody… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Abstract Anti-CD20 monoclonal antibodies have been successfully employed in the clinical treatment of non-Hodgkin's lymphomas in… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 4
  • figure 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
PURPOSE This multicenter phase II study evaluated the efficacy, dosimetry methodology, and safety of iodine-131 tositumomab in… Expand
Is this relevant?